Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05386251
Other study ID # 00003308
Secondary ID
Status Not yet recruiting
Phase Phase 2/Phase 3
First received
Last updated
Start date May 18, 2022
Est. completion date September 30, 2022

Study information

Verified date May 2022
Source Seattle Children's Hospital
Contact Margaret Sibley, Ph.D.
Phone 206) 884-1424
Email margaret.sibley@seattlechildrens.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to test the effectiveness of a telehealth-delivered skills training versus active control group for middle and high school students with ADHD symptoms. Both programs will be delivered digitally (via Zoom). Investigators will measure student functioning at baseline, post-group, and three-month follow-up. The primary outcomes are ADHD symptoms, student grade point average, and attendance as reported in the gradebook. Secondary outcomes include parent academic support, autonomy, academic motivation, and organization skills. Participant satisfaction with the group will be measured post-group. Group attendance and homework completion will also be measured.


Description:

120 middle and high school students with elevated ADHD symptoms will be recruited for this study, which will take place over the course of the 2021-2022 academic year. The recruitment strategy will be to distribute information about the study opportunity to educator email lists in South Florida (see appended email template). Educators will be instructed to share information about the study to the parents of students who perceive to experience ADHD symptoms in their schools, regardless of special education status or documentation of a disability. Students who enroll will be randomly assigned to either receive the STAND-G strategy-based group or a peer-support-based, active control group. Investigators will blind participants and their parents to which group is the active treatment by informing parents and students that participant will be randomly assigned to one of two groups to help improve school difficulties in youth. The two groups will be of equal duration, both will be led by the same instructors; and will differ only in content (teaching strategies vs. facilitating peer support and problem-solving conversations). Students (and their parents) will complete assessments at baseline, post-group, and three months post-group. School records will be obtained for all time points.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 120
Est. completion date September 30, 2022
Est. primary completion date September 30, 2022
Accepts healthy volunteers No
Gender All
Age group 11 Years to 17 Years
Eligibility Inclusion Criteria: Students will be required to, - be in the sixth through twelfth grade, - have elevated ADHD symptoms - documented impairment according to the SNAP - documented impairment according to Impairment Rating Scale. - Students must be 17.5 or younger at the time of enrollment to ensure that they are still under 18 at the expected completion of the study. Parents of eligible students will also participate. Exclusion Criteria: Students may not be, - in a self-contained special education classroom, - possess intellectual disability - be non-English speaking - be older than 18 years old at time of enrollment

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
BPT/OST
See Arm description.
Peer Support
See Arm description

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Seattle Children's Hospital

Outcome

Type Measure Description Time frame Safety issue
Other Treatment Satisfaction Parent and Self Report Satisfaction Survey At Post-treatment, approximately 8 weeks after initial group session
Other Treatment Fidelity Blinded Observers will observe to code for fidelity Through Treatment Completion, an average of 8 weeks
Other Treatment Barriers Parent an Self Reported Barriers Survey At Post-treatment, approximately 8 weeks after initial group session
Other Treatment Credibility Client Credibility Questionnaire-Parent and Self At Post-treatment, approximately 8 weeks after initial group session
Other Video Conferencing Feasibility Video-Conferencing Questionnaire-Parent and Self At Post-treatment, approximately 8 weeks after initial group session
Other Treatment Attendance Group records Through study completion, an average of 8 weeks, at each Session of Treatment
Other Treatment Homework Completion Group records Through study completion, an average of 8 weeks, at each Session of Treatment
Primary ADHD Symptoms Parent and Self Ratings on the SNAP Rating Scale Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Primary Academic Impairment: Grade Point Average Official School Records Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Primary Academic Impairment: School Attendance Official School Records Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Secondary Academic Motivation Expectancy-Value Questionnaire -Self Version Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Secondary Academic Motivation Change Ruler -Self Version Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Secondary Executive Functions BRIEF Rating Scale -Parent Version Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Secondary Organization, Time Management, and Planning Adolescent Academic Problems Checklist-Parent and Self Version will be used to measure organization, time management and planning Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Secondary Parent Academic Involvement Parent Academic Management Scale - Parent Version Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Secondary Academic Impairment Rating Scale Impairment Rating Scale - Parent Version Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Secondary Parent-Teen Conflict Conflict Behavior Questionnaire-20 - Parent, Self Version Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Secondary Goal Setting Goal Setting Questionnaire- Parent and Self Change from Baseline through 3 months after Post-Treatment, an average of 6 months
Secondary Parent Autonomy Support Parent Promotion of Volitional Functioning- Self Report Change from Baseline through 3 months after Post-Treatment, an average of 6 months
See also
  Status Clinical Trial Phase
Completed NCT03148782 - Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase N/A
Recruiting NCT06038942 - Formal Versus Informal Mindfulness Among University Students With Self-reported ADHD, Nonsuicidal Self-injury, or Stress N/A
Not yet recruiting NCT06456372 - Digital Health Intervention for Children With ADHD N/A
Completed NCT05518435 - Managing Young People With ADHD in Primary Care Study
Active, not recruiting NCT04978792 - Does Cultivating Self-compassion Improve Resilience to Criticism and Improve Mental Health in Adults With ADHD? N/A
Completed NCT03216512 - Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD N/A
Not yet recruiting NCT02906501 - Effect of Risperidone on Cognitive Functions in Adolescents With ADHD and Behavioral Disturbances N/A
Completed NCT02829528 - Little Flower Yoga for Kids: Evaluation of a Yoga and Mindfulness Program for Children With Increased Levels of Emotion Dysregulation and Inattention N/A
Completed NCT02900144 - Modified Comprehensive Behavioral Intervention for Tics (M_CBIT) N/A
Completed NCT02562469 - ACTIVATE: A Computerized Training Program for Children With ADHD N/A
Terminated NCT02271880 - Improving Medication Adherence in ADHD Adolescents N/A
Recruiting NCT02255565 - Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study Phase 4
Completed NCT02463396 - Mindfulness Training in Adults With ADHD N/A
Completed NCT01673594 - Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist Phase 4
Terminated NCT01733680 - Amiloride Hydrochloride as an Effective Treatment for ADHD Early Phase 1
Completed NCT02300597 - Internet-based Support for Young People With ADHD and Autism - a Controlled Study N/A
Active, not recruiting NCT01137318 - Combined Cognitive Remediation and Behavioral Intervention for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD) Phase 2
Completed NCT01404273 - Functional MRI of Relaxation Response Training in Adults With Attention-Deficit/Hyperactivity Disorder N/A
Completed NCT00573859 - The Reinforcing Mechanisms of Smoking in Adult ADHD Phase 1/Phase 2
Completed NCT00586157 - Study of Medication Patch to Treat Children Ages 6-12 With ADHD Phase 4